![AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | News Release:2018 | Eisai Co., Ltd. AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | News Release:2018 | Eisai Co., Ltd.](https://www.eisai.com/news/2018/images/news201846-1.jpg)
AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | News Release:2018 | Eisai Co., Ltd.
![Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations | Fierce Pharma Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1643820639/large.img_.png/large.img_.png?VersionId=Qe.Z8MhPo8.UNbqc4s7d3.fQ8QAisbYS)
Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations | Fierce Pharma
![Humira (Adalimumab Injection Solution for Subcutaneous Administration): Uses, Dosage, Side Effects, Interactions, Warning Humira (Adalimumab Injection Solution for Subcutaneous Administration): Uses, Dosage, Side Effects, Interactions, Warning](https://images.rxlist.com/images/rxlist/humira6.gif)